EMA shortages Shortage ongoing Medicine shortages
Insulin lispro Sanofi — supply shortage (shortage ongoing)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Insulin lispro Sanofi
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): insulin lispro
- Pharmaceutical forms affected: Solution for injection in a cartridge;Solution for injection in pre-filled pen
- Strengths affected: 100 units/ml solution for injection in cartridges;100 units/ml solution for injection in pre-filled pen
- Expected resolution: The expected duration of the shortage is unknown.
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗